Scarica l'app Stockscreener
21.68
0.23%
-0.05
Privia Health Group Inc Borsa (PRVA) Ultime notizie
Mountcastle sells multiple PRVA share blocks (NASDAQ: PRVA) - Stock Titan
Privia Health Group opens hiring for Sales Growth Director in Nashville to expand physician partnerships - Traders Union
Privia Health (PRVA) reports Q4: Everything you need to know ahead of earnings - MSN
Insider Sell: Parth Mehrotra Sells Shares of Privia Health Group Inc (PRVA) - GuruFocus
Mehrotra Parth, Privia Health CEO, sells $479k in PRVA stock By Investing.com - Investing.com South Africa
Mehrotra Parth, Privia Health CEO, sells $479k in PRVA stock - Investing.com India
Privia Health (PRVA) EVP awarded 28,268 restricted stock units - Stock Titan
Parth Mehrotra sells shares at PRVA (NASDAQ: PRVA) — Form 144 notice - Stock Titan
Privia Health (PRVA): Buy, Sell, or Hold Post Q4 Earnings? - Yahoo Finance
PRVA (NASDAQ: PRVA) files Form 144 reporting 21,097-share resale - Stock Titan
Parth Mehrotra Sells 41,999 Shares of Privia Health Group (NASDAQ:PRVA) Stock - MarketBeat
Privia Health Group (NASDAQ:PRVA) EVP Edward Fargis Sells 4,394 Shares - MarketBeat
Privia Health Group (NASDAQ:PRVA) EVP Edward Fargis Sells 4,949 Shares - MarketBeat
Privia Health Group (NASDAQ:PRVA) CFO David Mountcastle Sells 5,829 Shares - MarketBeat
Privia Health Group CEO Sells Over 63,000 Shares - TradingView
Privia Health Group (NASDAQ: PRVA) CEO sells shares to cover RSU taxes - Stock Titan
Tax-related share sale by Privia (PRVA) legal chief after RSU vesting - Stock Titan
Privia (PRVA) CFO in nondiscretionary tax sale of 11,006 shares - Stock Titan
(PRVA) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Insider sale notice: PRVA (NASDAQ: PRVA) files to sell 4,949 vested shares - Stock Titan
Insider sale notice lists recent disposals by PRVA (PRVA) reporting person - Stock Titan
Privia Health Group, Inc. (NASDAQ:PRVA) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Privia Health’s EHR Cancer Screening Gains Put Value Based Story In Focus - Yahoo Finance
Privia Health Group, Inc. $PRVA Shares Purchased by Rhenman & Partners Asset Management AB - MarketBeat
Privia Health Soars 9.98% to Hit Intraday High of $25.16 - Markets Mojo
Director sale notice: PRVA (NASDAQ: PRVA) files to sell 5,177 vested shares - Stock Titan
Is Privia Health Group (PRVA) Priced Attractive After Recent Share Price Swings - simplywall.st
Privia Health Earnings Call Highlights Growth And Cash - The Globe and Mail
PRVA Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Breaking Down Privia Health Gr: 5 Analysts Share Their Views - Benzinga
Citigroup Issues Pessimistic Forecast for Privia Health Group (NASDAQ:PRVA) Stock Price - MarketBeat
Marking National Colorectal Cancer Awareness Month, Privia Health Program Achieves 84% Colorectal Cancer Screening Rate Through Industry Collaboration - marketscreener.com
Marking National Colorectal Cancer Awareness Month, Privia Health Program Achieves 84% Colorectal Cancer Screening Rate Through Industry Collaboration – Company AnnouncementFT.com - Financial Times
Privia Health price target raised to $33 from $31 at Truist - Yahoo Finance
Royce & Associates LP Buys 214,166 Shares of Privia Health Group, Inc. $PRVA - MarketBeat
Matthew Shawn Morris Sells 16,550 Shares of Privia Health Group (NASDAQ:PRVA) Stock - MarketBeat
Matthew Shawn Morris Sells 7,788 Shares of Privia Health Group (NASDAQ:PRVA) Stock - MarketBeat
Privia Health Group (NASDAQ:PRVA) CFO David Mountcastle Sells 7,697 Shares - MarketBeat
Privia Health Group (NASDAQ:PRVA) CFO David Mountcastle Sells 5,361 Shares - MarketBeat
Privia Health Group Insider Sold Shares Worth $326,835, According to a Recent SEC Filing - marketscreener.com
Privia Health (PRVA) director sells 24,338 shares after option exercise - Stock Titan
Privia (NASDAQ: PRVA) CFO sells 13,058 shares via 10b5-1 plan - Stock Titan
PRVA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Privia Health Group (NASDAQ:PRVA) Stock Price Expected to Rise, Truist Financial Analyst Says - MarketBeat
Truist Adjusts Price Target on Privia Health to $33 From $31, Maintains Buy Rating - marketscreener.com
Jefferies Maintains Buy on PRVA Privia Health Group, Inc. Feb 2026 - Meyka
Privia Health Group (PRVA) Is Up 8.0% After Earnings Beat And Higher 2026 Revenue Outlook – Has The Bull Case Changed? - simplywall.st
Privia Health Expands Value Based Care Scale With Evolent ACO Acquisition - Yahoo Finance
Privia Health Group (PRVA) Is Up 8.0% After Raising 2026 Revenue Guidance and Beating Q4 Targets - Yahoo Finance
Privia Health Gr (PRVA) Receives Buy Rating with Increased Price Target | PRVA Stock News - GuruFocus
Decoding Privia Health Group Inc (PRVA): A Strategic SWOT Insigh - GuruFocus
PRVA Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Privia Health, Repligen, and RadNet Shares Plummet, What You Need To Know - The Globe and Mail
Privia Health Group (PRVA) Margin Expansion To 1.1% Tests High P E Narrative - simplywall.st
Canaccord Genuity Group Issues Positive Forecast for Privia Health Group (NASDAQ:PRVA) Stock Price - MarketBeat
Wall Street Analysts Think Privia Health (PRVA) Could Surge 25.45%: Read This Before Placing a Bet - sharewise.com
Privia Health Group, Inc. (NASDAQ:PRVA) Q4 2025 Earnings Call Transcript - Insider Monkey
Privia Health Group, Inc. SEC 10-K Report - TradingView
Privia Health (Nasdaq: PRVA) expands value-based care footprint - Stock Titan
Privia Health Group Q4 Earnings Call Highlights - MarketBeat
Privia Health (PRVA) Q4 2025 Earnings Transcript - AOL.com
0.79%
1.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):